ImmunoReagents Announces Exclusive German Distribution Channel with BioLeague.
(Raleigh, NC) -- ImmunoReagents, a manufacturer of high quality polyclonal antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Bioleague as its new distributor in Germany.
ImmunoReagents and Bioleague will work together to bring top quality antibodies to the German biotech, life science, and medical community. Germany is a European leader in life sciences and biotechnology. Germany currently has almost 550 biotechnology companies, as well as renowned research institutions and university research facilities. According to a 2011 study by the information platform biotechnology.de, the German biotechnology sector is growing, with record financing, rising numbers of biotechnology companies, and steady expenditures on research and development.
"This is a promising partnership for our company." said Ann Black, President and CEO of ImmunoReagents. "Working with Bioleague will allow us to extend into one of the world’s major biotech areas through an established, trusted company.”
About ImmunoReagents
ImmunoReagents is a leading global manufacturer of quality polyclonal antibodies used in research and in vitro diagnostics. They offer a wide range of secondary antibodies covering a broad spectrum of immunoglobulins from various species. Antibodies include various levels of cross species absorptions to provide high specificity. The Company also manufactures primary polyclonal antibodies to hormones, cancer markers, cardiac markers and serum proteins. In addition to its vast product lines, ImmunoReagents also provides custom manufacturing to meet specific customer requirements while adhering to cGMP guidelines and ISO quality systems requirements. The Company is located on NCSU’s Centennial Campus, the University-owned and operated research park and technology campus.
More information about ImmunoReagents: www.immunoreagents.com
About Bioleague
Bioleague is a distribution and consulting specialist for key components of the Life Science branch. They concentrate on innovative solutions in research and diagnostics. Life Science research institutes, medical routine labs, and the pharmaceutical and biotechnology industry use this specified knowledge to make routines easier and safer, and to do research more efficiently.
More information about Bioleague: www.bioleague.de
